Research article · 27 Feb 2021
Review articlePublished 2014
Statistical Designs for Pharmaceutical/Clinical Development
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In recent years, the concept of quality by design in (global) pharmaceutical development has received much attention. The purpose is to ensure that the compound under investigation will possess good drug characteristics such as identity, strength, purity, quality, safety, efficacy and stability before and post approval. A pharmaceutical development process consists of non-clinical (e.g., assay/process validation and stability testing), pre-clinical (e.g., animal and bioavailability/bioequivalence studies), and clinical (e.g., phases 1-3 clinical trials) development. In this article, various statistical designs that are commonly considered for achieving desired good drug characteristics as described in the United States Pharmacopeia and National Formulary (USP/NF) at various stages of non-clinical, pre-clinical, and clinical development are reviewed. In addition, the possible use of innovative adaptive clinical trial designs that may lead to (i) the identification of any signals, trends/patterns, and optimal clinical benefits of a test treatment under investigation, and (ii) increase the probability of success of the development process with limited resources available are discussed.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 2015
On Statistical Principles for Clinical Trials in Pharmaceutical Development and#8211; A Review of China FDA Draft Guidance
Review article · 2015
On Statistical Principles for Clinical Trials in Pharmaceutical Development – A Review of China FDA Draft Guidance
Research article · 28 Sep 2023
Implementation of Quality by Design Approach to Analytical Method Development and Validation for Estimation of Morniflumate Pharmaceutical Dosage Form
Research article · 3 May 2019
Development, Optimization and Validation of New Liquid Chromatographic Method for the Simultaneous Determination H1 Receptor Blockers in Bulk and their Pharmaceutical Formulations by Applying D-Optimal Mixture Design Methodology
More from this journal
The newest in Drug Designing: Open Access.
Research article · 19 Aug 2025
Spectroscopic, Quantum Chemical, Molecular Docking Studies on Cellulose Acetate: Polyvinylidene Fluoride Blend Polymer Membrane for Wound Healing
Research article · 18 Apr 2025
Molecular Docking Studies on Polyphenols of Moringa oleifera for its Enhanced Production of Heamoglobin and Impact of its Extracts on Drosophila melanogaster
Opinion · 4 Mar 2025
Structure-Based Drug Design: Advances in Targeting Oncogenic Kinases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDrug Designing: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Shein-Chung Chow”
- BylineArticles whose byline prints “Annpey Pong”

